Literature DB >> 15937651

Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report.

Masayasu Kato1, Naoyuki Ohe, Ayumi Okumura, Jun Shinoda, Asuka Nomura, Taro Shuin, Noboru Sakai.   

Abstract

We report a very rare case of hemangioblastomatosis in a patient without von Hippel-Lindau disease (VHL). A 50-year-old woman had a history of surgical procedures for total removal of a cerebellar hemangioblastoma (HB). Twenty-one years after the last operation, she developed communicating hydrocephalus; computed tomographic (CT) scans of the brain showed no recurrence of HB in the posterior fossa. Subsequently, she underwent placement of a ventriculo-peritoneal shunt. One year later, she was readmitted because of progressive numbness and pain in the left lower limb. Magnetic resonance imaging (MRI) showed multiple Gd-enhancing tumors around the brain stem, in the cerebellum, and in the cervical and thoracolumbar regions of the spine. She underwent surgical removal of the tumors in the cerebellum and spinal cord. Although the extirpated tissues were histopathologically verified HB with less than 1% MIB-1 labeling index, surgery was followed by external beam radiation therapy with doses of 40 Gy to the whole brain, 10 Gy to the posterior fossa and 30 Gy to the whole spine. However, she subsequently developed quadriparesis and became bedridden.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937651     DOI: 10.1007/s11060-004-2244-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

1.  Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.

Authors:  M Niemelä; S Lemeta; P Summanen; T Böhling; M Sainio; J Kere; K Poussa; R Sankila; H Haapasalo; H Kääriäinen; E Pukkala; J Jääskeläinen
Journal:  Acta Neurochir (Wien)       Date:  1999       Impact factor: 2.216

2.  Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings.

Authors:  R Bakshi; L L Mechtler; M J Patel; B D Lindsay; S Messinger; K J Gibbons
Journal:  J Neuroimaging       Date:  1997-10       Impact factor: 2.486

3.  Malignant spread of haemangioblastoma: report on two cases.

Authors:  J Mohan; B Brownell; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-06       Impact factor: 10.154

4.  Interferon alpha-2a therapy in 18 hemangioblastomas.

Authors:  M Niemelä; H Mäenpää; P Salven; P Summanen; K Poussa; L Laatikainen; J Jääskeläinen; H Joensuu
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

5.  Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.

Authors:  Robert J Weil; Alexander O Vortmeyer; Zhengping Zhuang; Svetlana D Pack; Nicholas Theodore; Robert K Erickson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-04       Impact factor: 5.115

6.  Hemangioblastomas: clinical and histopathological factors correlated with recurrence.

Authors:  S M de la Monte; S A Horowitz
Journal:  Neurosurgery       Date:  1989-11       Impact factor: 4.654

7.  Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.

Authors:  Jean François Girmens; Ali Erginay; Pascale Massin; Paul Scigalla; Alain Gaudric; Stéphane Richard
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

8.  Cerebellar hemangioblastomas.

Authors:  D I Sung; C H Chang; L Harisiadis
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

9.  Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery.

Authors:  S D Chang; J A Meisel; S L Hancock; D P Martin; M McManus; J R Adler
Journal:  Neurosurgery       Date:  1998-07       Impact factor: 4.654

10.  Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.

Authors:  M Yoshida; S Ashida; K Kondo; K Kobayashi; H Kanno; N Shinohara; N Shitara; T Kishida; S Kawakami; M Baba; I Yamamoto; M Hosaka; T Shuin; M Yao
Journal:  Jpn J Cancer Res       Date:  2000-02
View more
  8 in total

1.  CNS hemangioblastomatosis in a patient without von Hippel-Lindau disease.

Authors:  Arie Franco; Peter Pytel; Rimas V Lukas; Rupa Chennamaneni; John M Collins
Journal:  CNS Oncol       Date:  2017-04

2.  Cerebellar haemangioblastoma: a rare entity.

Authors:  Mehar Aziz; Kiran Alam; Manoranjan Varshney; Veena Maheshwari; Rana K Sherwani; Kavita Gaur; Vinod Kumar Srivastava
Journal:  BMJ Case Rep       Date:  2011-07-20

3.  Pituitary stalk hemangioblastoma in a von hippel-lindau patient : clinical course follow-up over a 20-year period.

Authors:  Kyung Mi Lee; Eui Jong Kim; Woo Suk Choi; Tae Sung Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-05-31

4.  Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease.

Authors:  Jiro Akimoto; Hirokazu Fukuhara; Tomohiro Suda; Kenta Nagai; Ryo Hashimoto; Kohno Michihiro
Journal:  Surg Neurol Int       Date:  2014-10-07

5.  Disseminated Hemangioblastoma of the Central Nervous System without Von Hippel-Lindau Disease.

Authors:  Sun-Yoon Chung; Sin-Soo Jeun; Jae-Hyun Park
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

6.  Retinal capillary hemangioblastoma and hemiretinal vein occlusion in a patient with primary congenital glaucoma: A case report.

Authors:  Abdulrahman F AlBloushi; Ibrahim Taskintuna; Sawsan R Nowilaty
Journal:  Saudi J Ophthalmol       Date:  2018-12-08

7.  Aggressive dissemination of central nervous system hemangioblastoma without association with von Hippel-Lindau disease: A case report and literature review.

Authors:  François Dantas; Jair Leopoldo Raso; Patrícia Salomé Gouvea Braga; Ricardo Vieira Botelho; Fernando Luiz Rolemberg Dantas
Journal:  Surg Neurol Int       Date:  2022-08-12

8.  Disseminated hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report.

Authors:  Hong-Rae Kim; Yeon-Lim Suh; Jong-Won Kim; Jung-Il Lee
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.